Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Bioventus Inc. (NASDAQ: BVS)
BVS Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
23.10%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
-18.10%
BVS Stock Analysis
BVS
PE Ratio:
20.9
BVS
PEG Ratio:
1.2
BVS
Forward EPS Growth (12 month):
18.10%
BVS
PS Ratio:
1
BVS
PSG Ratio:
0.1
BVS
Forward Revenue Growth (12 month):
6.80%
BVS Articles
No data was found